X-ray structure of human FPPS and use for selecting FPPS binding compounds

Details for Australian Patent Application No. 2006204523 (hide)

Owner Novartis AG

Inventors Strauss, Andre; Rondeau, Jean-Michel; Jahnke, Wolfgang; Geiser, Martin; Ramage, Paul

Agent Davies Collison Cave

Pub. Number AU-A-2006204523

PCT Pub. Number WO2006/072561

Priority 60/641,178 04.01.05 US

Filing date 2 January 2006

Wipo publication date 13 July 2006

International Classifications

C12N 9/10 (2006.01) Enzymes, e.g. ligases (6.) - Transferases (2.)

A61K 38/00 (2006.01) Medicinal preparations containing peptides

C12Q 1/48 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving transferase

C30B 29/58 (2006.01) Single crystals or homogeneous polycrystalline material with defined structure characterised by the material or by their shape

Event Publications

12 July 2007 PCT application entered the National Phase

  PCT publication WO2006/072561 Priority application(s): WO2006/072561

28 July 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006204524-Treatment of HCV disorders

2006204522-Aryl piperazine derivatives for the treatment of neuropsychiatric disorders